These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30507711)

  • 21. Impact of soy supplementation on sex steroids and vascular inflammation markers in postmenopausal women using tibolone: role of equol production capability.
    Törmälä R; Appt S; Clarkson TB; Mueck AO; Seeger H; Mikkola TS; Ylikorkala O
    Climacteric; 2008 Oct; 11(5):409-15. PubMed ID: 18781486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease.
    Joffe HV; Ridker PM; Manson JE; Cook NR; Buring JE; Rexrode KM
    Ann Epidemiol; 2006 Feb; 16(2):105-12. PubMed ID: 16216530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of raloxifene on activated protein C (APC) resistance in postmenopausal women and on APC resistance and homocysteine levels in elderly men: two randomized placebo-controlled studies.
    Duschek EJ; Neele SJ; Thomassen MC; Rosing J; Netelenbos C
    Blood Coagul Fibrinolysis; 2004 Oct; 15(8):649-55. PubMed ID: 15613919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density.
    Hofling M; Carlström K; Svane G; Azavedo E; Kloosterboer H; Von Schoultz B
    Gynecol Endocrinol; 2005 Feb; 20(2):110-5. PubMed ID: 15823831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study on relationship between endogenous androgens and insulin resistance at the different stages of postmenopause].
    Cao YK; Zhang SF; Zou SE; Xia X; Xu LN
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):740-4. PubMed ID: 24406129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating concentrations of hemostatic factors and two "steroid sensitive proteins" during oral hormone replacement therapy in women with coronary heart disease.
    Pripp U; Schenck-Gustafsson K; Landgren BM; Carlström K
    Scand J Clin Lab Invest; 2004; 64(7):659-65. PubMed ID: 15513323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
    Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
    Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in sex hormone-binding globulin, insulin, and serum lipids in postmenopausal women on a low-fat, high-fiber diet combined with exercise.
    Tymchuk CN; Tessler SB; Barnard RJ
    Nutr Cancer; 2000; 38(2):158-62. PubMed ID: 11525592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of the effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on blood coagulability.
    Skouby SO; Sidelmann JJ; Nilas L; Jespersen J
    Hum Reprod; 2007 Apr; 22(4):1186-91. PubMed ID: 17204528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex hormone-binding globulin in the diagnosis of peripheral tissue resistance to thyroid hormone: the value of changes after short term triiodothyronine administration.
    Sarne DH; Refetoff S; Rosenfield RL; Farriaux JP
    J Clin Endocrinol Metab; 1988 Apr; 66(4):740-6. PubMed ID: 3346353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis.
    Anagnostis P; Galanis P; Chatzistergiou V; Stevenson JC; Godsland IF; Lambrinoudaki I; Theodorou M; Goulis DG
    Maturitas; 2017 May; 99():27-36. PubMed ID: 28364865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The relationship of serum testosterone and its related index with the metabolism syndrome in women at perimenopausal or postmenopausal periods].
    Chen DM; Li YZ; Hong Y; Li CH; Liu Y; Xie MQ
    Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):115-20. PubMed ID: 22455743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of raloxifene on sex steroid hormones and C-telopeptide in postmenopausal women with primary breast cancer.
    Johansson H; Bonanni B; Mariette F; Cazzaniga M; Baglietto L; Guerrieri-Gonzaga A; Sandri MT; Luini A; Pelosi G; Decensi A
    Breast Cancer Res Treat; 2006 Jul; 98(2):167-72. PubMed ID: 16538534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of oral raloxifene on serum estradiol levels and other markers of estrogenicity.
    Reindollar R; Koltun W; Parsons A; Rosen A; Siddhanti S; Plouffe L;
    Fertil Steril; 2002 Sep; 78(3):469-72. PubMed ID: 12215319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].
    Reginster JY
    J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):541-9. PubMed ID: 12407324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene.
    Lambrinoudaki IV; Christodoulakos GE; Economou EV; Vlachou SA; Panoulis CP; Alexandrou AP; Kouskouni EE; Creatsas GC
    Maturitas; 2008 Jan; 59(1):62-71. PubMed ID: 18164562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women.
    Stomati M; Hartmann B; Spinetti A; Mailand D; Rubino S; Albrecht A; Huber J; Petraglia F; Genazzani AR
    J Endocrinol Invest; 1996 Sep; 19(8):535-41. PubMed ID: 8905477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
    Odlind V; Milsom I; Persson I; Victor A
    Acta Obstet Gynecol Scand; 2002 Jun; 81(6):482-90. PubMed ID: 12047300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short and long term effects of tibolone in postmenopausal women.
    Formoso G; Perrone E; Maltoni S; Balduzzi S; D'Amico R; Bassi C; Basevi V; Marata AM; Magrini N; Maestri E
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008536. PubMed ID: 22336846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dietary isoflavones affect sex hormone-binding globulin levels in postmenopausal women.
    Pino AM; Valladares LE; Palma MA; Mancilla AM; Yáñez M; Albala C
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2797-800. PubMed ID: 10946884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.